Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities

v3.19.3
Accrued Liabilities
 9 Months Ended
Sep. 30, 2019
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Liabilities
Accrued Liabilities
 
Accrued liabilities consisted of the following:
 
September 30,
2019
 
December 31,
2018
Salaries, benefits and related expenses
$
1,816

 
$
2,446

Device warranty
307

 
307

Clinical trials
301

 
227

Severance
—

 
270

Financing lease liability
30

 
35

Other
135

 
256

Total
$
2,589

 
$
3,541


 
A reconciliation of the changes in the current portion of the device warranty liability for the three and nine months ended September 30, 2019 and September 30, 2018 is as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 30, 2019
 
September 30, 2018
 
September 30, 2019
 
September 30, 2018
Balance at beginning of period
$
294

 
$
311

 
$
307

 
$
232

Additions for estimated future expense
113

 
99

 
293

 
312

Incurred costs
(100
)
 
(110
)
 
(293
)
 
(244
)
Balance at end of period
$
307

 
$
300

 
$
307

 
$
300